Introduction
We describe a case of systemic connective tissue disease (CTD) in a Malawian man in whom an autoimmune etiology was likely. Autoimmune CTDs are rarely reported in Africans [2] and there have been no case reports from Malawi. We were fortunate in that we were able to obtain additional tests on this patient including his autoantibody profile and HLA type which helped characterise his problem.
Case Presentantion
A 17 year-old student was referred to Queen Elizabeth Central Hospital (QECH) for management of progressive breathlessness. At the referring hospital he had been noted to have an abnormal chest X-ray (CXR) and had been treated for smear negative pulmonary TB (pTB). Having completed TB treatment there was no improvement and he was being considered for re-treatment for smear negative TB at the time of referral. At this point his case was reviewed. Breathlessness, which was worse on exertion, had been present for 18 months. It was not associated with cough or fevers. Joint pain, mainly affecting his hands, developed one month after the breathlessness. It was worse in the morning and associated with stiffness lasting more than 1 hour daily. He had noticed deformity of his hands. He occasionally had dry mouth but denied eye symptoms, Raynauds phenomenon or dysphagia. There was no relevant environmental exposure, past medical or family history. The only previous medication was anti-tuberculous drugs plus paracetamol. He did not drink alcohol nor smoke. On examination he was of small stature. He had no rashes. His eyes and mouth were normal. There was no cyanosis or lymphadenopathy and blood pressure was normal. The appearance of his hands is shown in figure 1 . The skin appeared thickened, shiny and tight with camptodactylia (sclerodactylia). There was no cutaneous calcinosis, ulceration or telangectasia. The distal phalanges were shortened with clubbing and/or pseudoclubbing of the nails. He had swelling and deformity of the wrists but other large joints appeared normal. Chest expansion was reduced bilaterally and auscultation was normal. His spleen was palpable 4cm below the costal margin. X rays of the hands are shown in Figure 2 . The most striking abnormality was acro-osteolysis 3 . Acro-osteolysis describes a destructive process involving one or more terminal phalnges. It is seen in a number of systemic and local conditions, most commonly systemic sclerosis (SSc) (box 1). His CXR (figure 3) showed possible hilar adenopathy and bilateral reticulonodular shadowing. Spirometry confirmed a severe restrictive lung defect; FEV1 1.27, FVC 1.27 (both <40% predicted). Urinanalysis: showed proteinuria +, no haematuria.
His serum creatinine was 38 micromol/l (ref. 62-106).
Although the resources of our hospital are limited, through collaboration with colleaguesoverseas we were able to define the patient's immune and biochemical status in more detail.
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Allain Theresa He was treated with NSAIDS, counseling and physiotherapy with symptomatic improvement. He reattended 18 months later due to deteriorating breathlessness. He was now short of breath at rest and had swollen ankles. Examination revealed progression of the skin changes in his hands with increased skin thickening, increased flexion and small ulcers overlying the PIP joints. He was cyanosed, O2 saturation 77%, blood pressure 90/60 mmHg and had signs of right ventricular failure. CXR showed widening of the cardiac silhouette, lung fields similar to previously. Spirometry was essentially unchanged. Echocardiography revealed massive dilation of the right ventricle and right atrium. A diagnosis of cor-pulmonale was made. He did not respond to treatment with diuretics and died peacefully at home 2 months later, under the care of the palliative care team.
Discussion
The patients prominent clinical features were pulmonary fibrosis and arthropathy. He had sclerodactylia with pseudoclubbing 4, 5 due to acro-osteolysis and/or clubbing due to Figure 3 Chest X ray taken when first seen at our hospital (18 months after symptom onset).
pulmonary disease with joint space narrowing in the proximal inter-phalyngeal (PIP) joints. These clinical features most closely fit with systemic sclerosis, although there were some a typical features. The radiograph findings are compatible with changes seen in scleroderma but not with rheumatoid arthritis (RA). Systemic sclerosis is said to occur world-wide, although the only reports from Sub-Saharan Africa are from South Africa 2 . The incidence is 10/million population/year. The male :female ratio is 3:1 and the peak age of onset 30-50 years. Scleroderma-like syndromes can be triggered by environmental exposure to vinyl chloride, silica dust, adulterated rape seed oil and trichloroethylene but exposure to these was not reported in our patient. Acro-osteolysis can be seen in a number of conditions 3 box 1 , but in this case SSc was most likely. In patients with SSc, acro-osteolysis is significantly associated with digital ulceration and systemic complications, such as pulmonary fibrosis 1 . This combination of features was seen in our patient. The overall prognosis for SSc is 55% 10 year survival, with most patients dying from pulmonary, cardiac or renal involvement. As in our case, 80% of SSc patients have positive anti-nuclear antibodies, however the pattern of autoantibodies in our patient is different from that typically described. Disseminated SSc is associated with Scl-70/antitopoisomerase 1 in up to 50% of cases. In this patient the ENA was positive, with a strong SSA signal. SSA or anti-Ro antibodies are primarily found in patients with SLE and Sjögren's syndrome. Clinically our patient did not have either of these conditions. SSA antibodies are infrequently seen in other connective tissue diseases such as scleroderma, polymyositis, mixed connective tissue disease, and RA. Among patients with anti-Ro/ SSA antibodies and initially undifferentiated connective tissue disease, only around 25% evolve to a more defined CTD (most often Sjögren's). Racial differences in the clinical features, auto-antibody profile and genetic associations of SSc have been described. Case series reported from the USA and South Africa demonstrate that among patients with systemic sclerosis blacks are more likely to have progressive pulmonary interstitial fibrosis and worse outcomes 2, 6, 7 . In caucasian populations SSc is associated with HLA A1, B8, DR3, DR5, DRw52 and DR4 which were not present in our patient. However, our patient had HLA class 11 type DRB1*11. This HLA type has been 
Conclusion
In summary this is a case of a young patient with a rapidly progressive disease with several features suggesting an autoimmune process, particularly systemic sclerosis. However, he also had severe erosive arthopathy and an autoantibody profile suggesting Sjogren's syndrome consistent with the observation that CTDs in Africans may present differently than in Caucasians and have different underlying immune mechanisms. The case illustrates an important lesson; that some patients with a common presentation (breathlessness and an abnormal CXR), may have rare conditions. In our patient a thorough history and examination revealed additional findings that pointed to the correct diagnosis.
